CMC considerations for biosimilar drug development
Ulrike Konrad
Search for unknown immunogenicity: An overview
Rosa Helena Bustos Cruz
Development of Etanercept biosimilar ErelziTM
Tim Demuth, Antonio Da Silva, Martin Schiestl and Cornelius Fritsch
Development and in-vivo evaluation of Ofloxacin gastro-retentive drug delivery system
Dina E Abo Elezz, Ahmed H El-Shafeey and Yousry M El-Sayed
Evidence-based approach of CT-P13 to meet the expectations of different stakeholders
Stanley Seung Suh Hong
Multilevel characterization of biosimilars by CE-LIF and CE-MS
Andras Guttman
Zapata C, Esteban E, Garcia J, Jauregui E and Bustos R H
Armenia Nazar, Muhammad Arief, Mifta Huljannah, Yori Yuliandra and Helmi Arifin
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report